Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2012

Aug 17, 2012

29777_dirs_2012-08-17_d43436ad-862d-4b12-8966-2dbce91c90f2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-08-16

Reporting Person: Warmuth Michael J (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-16 Common shares without par value M 9400 $44.16 Acquired 54025 Direct
2012-08-16 Common shares without par value S 1947 $66.46 Disposed 52078 Direct
2012-08-16 Common shares without par value S 1900 $66.47 Disposed 50178 Direct
2012-08-16 Common shares without par value S 5553 $66.48 Disposed 44625 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-16 Option (right to buy) $44.16 M 9400 Disposed 2016-02-16 Common shares (9400) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 25337 Indirect

Footnotes

F1: Held in the Stefanie M. Warmuth Revocable Trust. The reporting person and his spouse are trustees of the trust. The trust is revocable by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.